Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Neuroscience Optimization of GlyT1 Inhibitor

NCT01911676 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01911676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01911676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Neuroscience Optimization of GlyT1 Inhibitor
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
December 31, 2018
Enrollment
71 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairments associated with schizophrenia